Keywords: fda, review, taxotere, food, drug, administration, oncologic
FDA To Review Taxotere
Article | 31 October 1994
- The US Food and Drug Administration's Oncologic Drugs Advisory Committee is to review Rhone-Poulenc Rorer's application for Taxotere (docetaxel) on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
